Baystreet Staff - Tuesday, November 15, 2016 iCo Therapeutics 11:42 AM EST - iCo Therapeutics : Announced a World Wide Exclusive Option and EU License Rights with Laboratorios SALVAT for a Novel Glaucoma Asset. iCo Therapeutics shares V.ICO are trading up $0.035 at $0.08.